Development of Low-Cost, Weight-Adjustable Clofazimine Mini-Tablets for Treatment of Tuberculosis in Pediatrics
Published in the European Journal of Pharmaceutical Sciences on May 18, 2023
Check out MCIDT Affiliate Dr. Ashlee Brunaugh’s research on developing pediatric-friendly delivery dosages and the potential cost-effective technologies to improve the bioavailability of the poorly water-soluble drug Clofazimine to treat tuberculosis.